Michele Maio

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 4 papers. Top paper: “Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma”.

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

New England Journal of Medicine(2015)10.1056/nejmoa1504030

N/A

1.3DataRank · unranked

8085 citations

Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C. Lance Cowey, Christopher D. Lao +35 more

First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-005813

N/A

0.810DataRank · unranked

25 citations

Jean‐Laurent Deville, Mario Sznol, Alain Ravaud, Marco Maruzzo, Russell K. Pachynski +14 more

Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detection

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.20.683167

N/A

0.208DataRank · unranked

3 citations

Piera Grisolia, Raffaella Giuffrida, Clara Iannarone, Cinzia Graziano, Marianna Scrima +35 more

Immune correlates of metastatic melanoma patients treated with ipilimumab in combination with fotemustine in the phase II NIBIT-M1 study

Journal for ImmunoTherapy of Cancer(2013)10.1186/2051-1426-1-s1-p107

N/A

0DataRank · unranked

0 citations

Hugues Nicolay, Filippo Capocefalo, Ester Fonsatti, Carla Chiarucci, Ornella Cutaia +5 more